Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Plasma Lipid Profile Reveals Plasmalogens as Potential Biomarkers for Colon Cancer Screening

Full text
Author(s):
Show less -
Fernandes, Anna Maria A. P. [1] ; Messias, Marcia C. F. [1] ; Duarte, Gustavo H. B. [2] ; de Santis, Gabrielle K. D. [1] ; Mecatti, Giovana C. [1] ; Porcari, Andreia M. [1] ; Murgu, Michael [3] ; Simionato, Ana Valeria C. [4, 5] ; Rocha, Thalita [1] ; Martinez, Carlos A. R. [1] ; Carvalho, Patricia O. [1]
Total Authors: 11
Affiliation:
[1] Sao Francisco Univ, Lab Multidisciplinary Res, BR-12916900 Braganca Paulista, SP - Brazil
[2] Univ Estadual Campinas, Inst Chem IQ, UNICAMP, BR-13083970 Campinas, SP - Brazil
[3] Waters Technol Brazil, Luiz Barssotti Applicat Lab, BR-06455020 Barueri, SP - Brazil
[4] Natl Inst Sci & Technol Bioanalyt, UNICAMPCampinas, IQ, BR-13083970 Sao Paulo - Brazil
[5] Univ Estadual Campinas, IQ, BR-13083970 Campinas, SP - Brazil
Total Affiliations: 5
Document type: Journal article
Source: METABOLITES; v. 10, n. 6 JUN 2020.
Web of Science Citations: 0
Abstract

In this era of precision medicine, there is an increasingly urgent need for highly sensitive tests for detecting tumors such as colon cancer (CC), a silent disease where the first symptoms may take 10-15 years to appear. Mass spectrometry-based lipidomics is an emerging tool for such clinical diagnosis. We used ultra-performance liquid chromatography coupled to electrospray ionization quadrupole time-of-flight mass spectrometry operating in high energy collision spectral acquisition mode (MSE) mode (UPLC-QTOF-MSE) and gas chromatography (GC) to investigate differences between the plasmatic lipidic composition of CC patients and control (CTR) subjects. Key enzymes in lipidic metabolism were investigated using immuno-based detection assays. Our partial least squares discriminant analysis (PLS-DA) resulted in a suitable discrimination between CTR and CC plasma samples. Forty-two statistically significant discriminating lipids were putatively identified. Ether lipids showed a prominent presence and accordingly, a decrease in glyceronephosphate O-acyltransferase (GNPAT) enzyme activity was found. A receiver operating characteristic (ROC) curve built for three plasmalogens of phosphatidylserine (PS), named PS(P-36:1), PS(P-38:3) and PS(P-40:5), presented an area under the curve (AUC) of 0.998, and sensitivity and specificity of 100 and 85.7% respectively. These results show significant differences in CC patients' plasma lipid composition that may be useful in discriminating them from CTR individuals with a special role for plasmalogens. (AU)

FAPESP's process: 17/25017-4 - Solid-phase microextraction and gas chromatography in the lipidomic analysis of colorectal cancer patients' plasma
Grantee:Gabrielle Kristine Doratiotto de Santis
Support Opportunities: Scholarships in Brazil - Scientific Initiation
FAPESP's process: 18/13317-6 - A lipidomics study applied to Rectal Cancer: biochemical-molecular mechanisms and assessment of the response to neoadjuvant therapy
Grantee:Patrícia de Oliveira Carvalho
Support Opportunities: Regular Research Grants